GSK Plc (GSK)
47.03
-0.15
(-0.32%)
USD |
NYSE |
Oct 02, 16:00
47.02
-0.01
(-0.02%)
After-Hours: 20:00
GSK Price : 47.03 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 47.08 | 47.16 | 46.84 | 47.03 | 5.386M |
| Oct 01, 2026 | 48.16 | 48.23 | 47.13 | 47.18 | 7.898M |
| Sep 30, 2026 | 48.92 | 49.05 | 48.17 | 48.17 | 5.853M |
| Sep 29, 2026 | 49.40 | 49.82 | 48.96 | 49.35 | 2.893M |
| Sep 28, 2026 | 49.17 | 49.80 | 48.98 | 49.70 | 3.587M |
| Sep 25, 2026 | 49.49 | 49.50 | 49.00 | 49.24 | 3.324M |
| Sep 24, 2026 | 49.59 | 50.14 | 49.56 | 49.65 | 2.839M |
| Sep 23, 2026 | 50.18 | 50.74 | 49.67 | 49.71 | 3.041M |
| Sep 22, 2026 | 50.69 | 50.99 | 50.22 | 50.72 | 4.296M |
| Sep 21, 2026 | 50.75 | 51.32 | 50.46 | 51.08 | 2.872M |
| Sep 18, 2026 | 50.20 | 50.33 | 49.50 | 50.22 | 4.709M |
| Sep 17, 2026 | 50.72 | 51.08 | 50.62 | 51.06 | 3.075M |
| Sep 16, 2026 | 50.19 | 50.71 | 50.06 | 50.29 | 2.845M |
| Sep 15, 2026 | 49.69 | 50.16 | 49.63 | 50.01 | 2.740M |
| Sep 14, 2026 | 50.29 | 50.30 | 49.61 | 50.05 | 3.004M |
| Sep 11, 2026 | 48.70 | 48.80 | 47.85 | 48.13 | 2.277M |
| Sep 10, 2026 | 48.47 | 48.59 | 47.98 | 48.12 | 2.151M |
| Sep 09, 2026 | 48.82 | 49.16 | 48.60 | 48.63 | 2.405M |
| Sep 08, 2026 | 49.00 | 49.23 | 48.54 | 48.54 | 3.062M |
| Sep 04, 2026 | 49.70 | 50.06 | 49.66 | 49.89 | 2.287M |
| Sep 03, 2026 | 51.50 | 51.52 | 50.19 | 50.87 | 2.443M |
| Sep 02, 2026 | 50.36 | 51.08 | 50.04 | 50.44 | 2.938M |
| Sep 01, 2026 | 51.11 | 51.26 | 50.46 | 50.66 | 3.272M |
| Aug 31, 2026 | 50.62 | 50.82 | 50.25 | 50.25 | 2.394M |
| Aug 28, 2026 | 50.22 | 50.88 | 49.95 | 50.82 | 3.432M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AstraZeneca PLC | 156.90 |
| Johnson & Johnson | 256.03 |
| Eli Lilly & Co. | 1142.85 |
| Merck & Co., Inc. | 144.30 |
| Novo Nordisk A/S | 37.32 |
Price Related Metrics
| PE Ratio | 14.82 |
| PS Ratio | 2.154 |
| PEG Ratio | 0.309 |
| Price to Book Value | 4.062 |
| Price to Free Cash Flow | 14.49 |
| Earnings Yield | 6.75% |
| Market Cap | 95.13B |
| PEGY Ratio | 0.2858 |
| Operating PE Ratio | 8.615 |
| Normalized PE Ratio | 10.20 |